$CME
CME Group Inc.
World's largest derivatives marketplace for futures and options.
CME key facts as of November 14, 2026
- Latest AI research report
- CME Group: Valuation, Volume and Risks (as of November 14, 2026)
- StockAlpha report sentiment
- Neutral (as of November 14, 2026)
- Analyst consensus
- Buy (5 Strong Buy, 4 Buy, 6 Hold, 1 Sell, 1 Strong Sell) (as of November 1, 2026)
- Analyst price target
- $317.91 mean (range $227.00 to $367.00) (as of November 20, 2026)
- Sector
- Finance
Analysis from Nov 14, 2026
CME Group: Valuation, Volume and Risks
CME Group reported a quarterly earnings beat and set a new volume record in Lean Hog futures and options, while revenue and earnings growth remain positive in the available data. Its share price is close to the analyst mean target, leaving valuation, trading activity and macroeconomic conditions central to the outlook.
Previous Reports
CME FAQ
What is StockAlpha's latest view on CME?
StockAlpha's latest AI research report on CME Group Inc. (CME), "CME Group: Valuation, Volume and Risks", was published on November 14, 2026 and rates the overall sentiment as neutral. CME Group reported a quarterly earnings beat and set a new volume record in Lean Hog futures and options, while revenue and earnings growth remain positive in the available data. Its share price is close to the analyst mean target, leaving valuation, trading activity and macroeconomic conditions central to the outlook.
When was the CME research last updated?
The most recent CME report was published on November 14, 2026.
What do analysts expect for CME?
As of November 1, 2026, the analyst consensus on CME is Buy (5 Strong Buy, 4 Buy, 6 Hold, 1 Sell, 1 Strong Sell). As of November 20, 2026, the analyst price target is $317.91 mean (range $227.00 to $367.00).
Is this CME research investment advice?
No. StockAlpha.ai research is AI-generated analysis for informational purposes only and is not investment advice. Analyst figures are third-party data. Do your own research before making investment decisions.
Keep exploring
- draft CME Group into a free practice contest: How to put the stock you just researched into a contest lineup at no real-money risk
- the finance sector brief for context on CME Group's peers: Today's sector-level news and moves around the stock